Taselisib (GDC 0032) is a potent, next-generation ? isoform-sparing PI3K inhibitor targeting PI3K?/?/? with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3K?.
choosing a selection results in a full page refresh
Product has been added to your wishlist.
You can view your wishlist by creating or login account.
Please create account through ##customer_email## email
